Clinical Trials Logo

Clinical Trial Summary

The relationship between exposure to air pollution and spondyloarthritis (SpA) has been poorly studied. Based on data from the literature on other inflammatory pathologies such as rheumatoid arthritis, we hypothesize that there is a relationship between exposure to air pollution and the risk of presenting a flare-up in SpA patients following and living in Franche-Comté (France). Primary objective:The potential relationship between exposure to air pollution (nitrogen dioxide, fine particles with a diameter of less than 10 or 2.5 microns and Ozone) and the onset of a spondyloarthritis flare-up will be explored in patients with this pathology.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06077604
Study type Observational
Source Centre Hospitalier Universitaire de Besancon
Contact Sophie Pujol, PhD
Phone +33381219049
Email spujol@chu-besancon.fr
Status Not yet recruiting
Phase
Start date October 15, 2023
Completion date October 15, 2025

See also
  Status Clinical Trial Phase
Not yet recruiting NCT06059430 - Cohort Project of Patients With Inflammatory Rheumatism
Not yet recruiting NCT03940911 - Fatigue and Skeletal Muscle Impact in Severe Axial Spondyloarthritis N/A
Recruiting NCT06114407 - Baricitinib in the Treatment of Refractory Axial Spondyloarthritis Patients: A Comparison With Tofacitinib Phase 2
Not yet recruiting NCT06454188 - A Study to Evaluate the Impact of Upadacitinib on Spondyloarthritis Outcomes in Patients With Active Psoriatic Arthritis Phase 4
Recruiting NCT06259890 - Influence of Sodium Intake in spondyLoarthriTes N/A
Not yet recruiting NCT06261931 - Severity Over Time of Early Forms of Spondyloarthritis
Completed NCT00741793 - Biologic Treatment Registry Across Canada